title: Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death.
authors.forename: Mark D
authors.initials: MD
authors.lastname: Williams
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Janes
authors.forename: David R
authors.initials: DR
authors.lastname: Nelson
mesh_terms: D018806:APACHE; D006801:Humans; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012307:Risk Factors; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated